Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05217602 · ClinicalTrials.gov registry record · NA
Incentivizing Meditation App Habit Formation
A NA study of Stress and Adherence, Treatment, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 597
- Enrollment target
- 1
- Study location
NCT05217602 is a NA study of Stress and Adherence, Treatment that has completed, run by Arizona State University. The registered enrollment target is 597 participants, below the 782-participant average among 152 other Stress trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05217602, a NA study of Stress and Adherence, Treatment, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 597 participants
- Enrollment target
- 1
- Study location
Study Summary
Over 75% of U.S. adults report significant stress, resulting in major health and economic costs. Mobile meditation apps are a feasible, effective, and scalable strategy for self-managing stress that is rapidly growing in popularity and thus represent a key tool for improving public health. However, existing intervention strategies for establishing persistent mobile health app adherence have largely been unsuccessful. Thus, there is a need for alternative strategies to move those who initiate meditation, i.e. new paying subscribers to a mobile meditation app. The investigators propose to synthesize theory- and evidence-based intervention approaches from psychology and behavioral economics to test novel combined strategies for establishing persistent adherence to meditation using the scalable Calm app. The purpose of this study is to evaluate the use of anchoring strategies in combination with pragmatic in-kind rewards to identify the most optimal strategy for establishing persistent meditation habits with a mobile app. The investigators aim to assess the adherence persistence to a 10 minutes per day Calm prescription in new, paying self-initiated Calm subscribers; investigate the mediating effect of anchoring plan adherence on adherence persistence to the Calm prescription; and estimate the dynamic relationship between meditation adherence and stress. The investigators hypothesize that participants using anchoring strategies in combination with pragmatic in-kind rewards will be more likely to adhere to the Calm prescription than the control condition with greater adherence observed among those participating in the anchoring plus time-contingent reward intervention; greater adherence to anchoring plans will lead to higher adherence persistence; and greater reductions in stress will be associated with more persistent meditation adherence across study groups. Investigators aim to recruit N=555 new, paying self-initiated Calm subscribers. Participants will be randomize
Conditions Studied
Interventions
- BEHAVIORAL AC+ARwdC
- BEHAVIORAL AC+RwdC
- BEHAVIORAL Usual Calm Control (UC)
Study Locations (1)
Arizona
- Arizona State University - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 597 participants |
| Start Date | 2022-02-22 |
| Est. Completion | 2022-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05217602
The ClinicalTrials.gov registry entry for NCT05217602 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 597 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 782-participant average among 152 other Stress trials with a reported enrollment target (24% lower). The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Stress appearing as the primary indexed condition, and to 3 interventions - of which AC+ARwdC is the first listed.
NCT05217602 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT05217602 about?
NCT05217602 is a clinical study titled "Incentivizing Meditation App Habit Formation". Over 75% of U.S. adults report significant stress, resulting in major health and economic costs. Mobile meditation apps are a feasible, effective, and scalable strategy for self-managing stress that is rapidly growing in popularity and thus represent a key tool for improving public health. However, ...
What is the current status of trial NCT05217602?
This trial is currently completed. It is a NA study. The enrollment target is 597 participants. The study started on 2022-02-22. Estimated completion is 2022-10-31.
What conditions does trial NCT05217602 study?
This clinical trial studies the following conditions: Stress, Adherence, Treatment.
What interventions are being tested in trial NCT05217602?
The interventions under investigation include: AC+ARwdC (BEHAVIORAL), AC+RwdC (BEHAVIORAL), Usual Calm Control (UC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05217602?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05217602 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mindfulness-Based Intervention With a Supplement for Stress-Related Problems in College Students Across Multiple Sites (4SITE)
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
ACT for HIV-Positive Men
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.